JPMorgan cuts Semen Indonesia stock rating to underweight

Published 08/05/2025, 06:54
JPMorgan cuts Semen Indonesia stock rating to underweight

On Thursday, JPMorgan analysts downgraded Semen Indonesia Persero Tbk PT (SMGR:IJ) (OTC: PSGTY) stock rating from Overweight to Underweight and significantly reduced the price target to IDR1,800.00 from IDR4,530.00. The stock, currently trading at $3.35, has already declined over 30% in the past six months. The revision follows a notable decline in the company’s quarterly earnings since the second half of 2024, primarily driven by a decrease in bag cement performance. InvestingPro data shows the company maintains a prominent position in the Construction Materials industry, despite recent challenges.

Semen Indonesia, a holding company that operates 17 subsidiaries through a centralized operation scheme, has seen its domestic bag cement market share drop to 46% as of March 2025, compared to over 50% in the past two years. While the company maintains an impressive 33-year streak of dividend payments, its financial health metrics from InvestingPro indicate some concerns, with revenue declining 6.89% in the last twelve months. The analyst pointed out that the bag cement segment is retail-driven and subject to diverse demand dynamics in local regions. Smaller competitors have been able to quickly adapt to these dynamics, often through faster pricing actions, while Semen Indonesia’s approach through regional distributors offers less detailed sales and marketing strategies.

The downgrade reflects concerns that Semen Indonesia’s market share in the bag cement market will continue to diminish, potentially leading to negative operating leverage. JPMorgan has adjusted its earnings projections for 2025 and 2026 downwards by more than 30%, placing them approximately 15% below consensus estimates.

The new price target of IDR1,800.00 is based on a 4x EV/EBITDA valuation, as stated by JPMorgan. This adjustment indicates a more cautious outlook on the company’s financial performance and market position in the upcoming period. The firm’s analysis suggests that the challenges faced by Semen Indonesia in maintaining its market share and adapting to local demand fluctuations are likely to persist, affecting its earnings potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.